These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9718628)

  • 1. Positron emission tomography studies of abnormal glucose metabolism in schizophrenia.
    Buchsbaum MS; Hazlett EA
    Schizophr Bull; 1998; 24(3):343-64. PubMed ID: 9718628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography studies of abnormal glucose metabolism in schizophrenic illness.
    Buchsbaum MS
    Clin Neurosci; 1995; 3(2):122-30. PubMed ID: 7583618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward a brain map of auditory hallucinations.
    Cleghorn JM; Franco S; Szechtman B; Kaplan RD; Szechtman H; Brown GM; Nahmias C; Garnett ES
    Am J Psychiatry; 1992 Aug; 149(8):1062-9. PubMed ID: 1353314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visualizing fronto-striatal circuitry and neuroleptic effects in schizophrenia.
    Buchsbaum MS; Hazlett EA; Haznedar MM; Spiegel-Cohen J; Wei TC
    Acta Psychiatr Scand Suppl; 1999; 395():129-37. PubMed ID: 10225342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative glucose metabolic rate higher in white matter in patients with schizophrenia.
    Buchsbaum MS; Buchsbaum BR; Hazlett EA; Haznedar MM; Newmark R; Tang CY; Hof PR
    Am J Psychiatry; 2007 Jul; 164(7):1072-81. PubMed ID: 17606659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics.
    Buchsbaum MS; Haier RJ; Potkin SG; Nuechterlein K; Bracha HS; Katz M; Lohr J; Wu J; Lottenberg S; Jerabek PA
    Arch Gen Psychiatry; 1992 Dec; 49(12):935-42. PubMed ID: 1360198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia.
    Szechtman H; Nahmias C; Garnett ES; Firnau G; Brown GM; Kaplan RD; Cleghorn JM
    Arch Gen Psychiatry; 1988 Jun; 45(6):523-32. PubMed ID: 2897836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
    Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
    Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine effects on glucose metabolic rate in striatum and frontal cortex.
    Potkin SG; Buchsbaum MS; Jin Y; Tang C; Telford J; Friedman G; Lottenberg S; Najafi A; Gulasekaram B; Costa J
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():63-6. PubMed ID: 7961576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered frontostriatal relationship in unmedicated schizophrenic patients.
    Biver F; Goldman S; Luxen A; Delvenne V; De Maertelaer V; De La Fuente J; Mendlewicz J; Lotstra F
    Psychiatry Res; 1995 Sep; 61(3):161-71. PubMed ID: 8545500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcortical structures in aphasia. An analysis based on (F-18)-fluorodeoxyglucose, positron emission tomography, and computed tomography.
    Metter EJ; Riege WH; Hanson WR; Jackson CA; Kempler D; van Lancker D
    Arch Neurol; 1988 Nov; 45(11):1229-34. PubMed ID: 3263849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.
    Holcomb HH; Cascella NG; Thaker GK; Medoff DR; Dannals RF; Tamminga CA
    Am J Psychiatry; 1996 Jan; 153(1):41-9. PubMed ID: 8540590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional selectivity in clozapine treatment?
    Kessler RM; Meltzer HY
    Am J Psychiatry; 2002 Jun; 159(6):1064-5. PubMed ID: 12042207
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlational patterns of cerebral glucose metabolism in never-medicated schizophrenics.
    Katz M; Buchsbaum MS; Siegel BV; Wu J; Haier RJ; Bunney WE
    Neuropsychobiology; 1996; 33(1):1-11. PubMed ID: 8821368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study.
    Farkas T; Wolf AP; Jaeger J; Brodie JD; Christman DR; Fowler JS
    Arch Gen Psychiatry; 1984 Mar; 41(3):293-300. PubMed ID: 6608333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.
    Wolkin A; Jaeger J; Brodie JD; Wolf AP; Fowler J; Rotrosen J; Gomez-Mont F; Cancro R
    Am J Psychiatry; 1985 May; 142(5):564-71. PubMed ID: 3872603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia.
    Volkow ND; Wolf AP; Van Gelder P; Brodie JD; Overall JE; Cancro R; Gomez-Mont F
    Am J Psychiatry; 1987 Feb; 144(2):151-8. PubMed ID: 3492931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography.
    Cohen RM; Semple WE; Gross M
    Psychiatr Clin North Am; 1986 Mar; 9(1):63-79. PubMed ID: 3515332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic effects on regional brain metabolism in first episode schizophrenics.
    Cleghorn JM; Szechtman H; Garnett ES; Brown GM; Nahmias C; Szechtman B; Kaplan R; Franco S
    Schizophr Res; 1991 Oct; 5(3):208-9. PubMed ID: 1684720
    [No Abstract]   [Full Text] [Related]  

  • 20. Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features.
    Gur RE; Mozley PD; Resnick SM; Mozley LH; Shtasel DL; Gallacher F; Arnold SE; Karp JS; Alavi A; Reivich M
    Arch Gen Psychiatry; 1995 Aug; 52(8):657-67. PubMed ID: 7632119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.